FDA Inspection 717037 — Janssen Biotech Inc.

Janssen Biotech Inc. — FEI 3006473233

The FDA completed an inspection of Janssen Biotech Inc. on Apr 14, 2011 in Horsham, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 14, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Postmarket Surv. and Epidemiology
Location
Horsham, PA (United States)

Citations

IDCFRDescription
241921 CFR 211.198(a)Complaint Handling Procedure

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.